Status:
RECRUITING
Assessment of Risks of Perinephric Fat Thickness to Adverse Renal Outcomes Post Donor Nephrectomy
Lead Sponsor:
Mayo Clinic
Conditions:
Living Kidney Donation
Hypertension
Eligibility:
All Genders
18-80 years
Brief Summary
The goal of this observational study is to learn if PRAT thickness is a marker of visceral obesity and its influence on donors' kidney function and blood pressure in living kidney donors. Population i...
Detailed Description
6.1 Screening Visit Patients who have had their donor nephrectomy scheduled will be approached for enrollment. Potential participants must preliminarily meet all inclusion and no exclusion criteria to...
Eligibility Criteria
Inclusion
- Participants in this study will be restricted to living kidney transplant donors (LKDs). .
Exclusion
- Those who do not meet Mayo Clinic Rochester's clinical criterion for donor nephrectomy.
- \>10% weight change between the donor evaluation and donor nephrectomy
- Individuals who are pregnant or are planning to become pregnant
- Inability to comply with study procedures or any condition that, in the opinion of the investigator, could increase the patient's risk by participating in the study or confound the outcome of the study.
Key Trial Info
Start Date :
February 10 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 10 2028
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06886087
Start Date
February 10 2025
End Date
February 10 2028
Last Update
November 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905